Iterum Therapeutics Statistics
Total Valuation
ITRM has a market cap or net worth of $19.18 million. The enterprise value is $41.91 million.
Important Dates
The next estimated earnings date is Friday, March 20, 2026, before market open.
| Earnings Date | Mar 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ITRM has 52.84 million shares outstanding. The number of shares has increased by 124.80% in one year.
| Current Share Class | 52.84M |
| Shares Outstanding | 52.84M |
| Shares Change (YoY) | +124.80% |
| Shares Change (QoQ) | +14.69% |
| Owned by Insiders (%) | 0.79% |
| Owned by Institutions (%) | 5.99% |
| Float | 52.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 34.13 |
| Forward PS | 2.16 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 107.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.13
| Current Ratio | 2.13 |
| Quick Ratio | 1.80 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.53 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -53.28% |
| Return on Invested Capital (ROIC) | -133.17% |
| Return on Capital Employed (ROCE) | -79.16% |
| Weighted Average Cost of Capital (WACC) | 10.48% |
| Revenue Per Employee | $43,333 |
| Profits Per Employee | -$3.00M |
| Employee Count | 9 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ITRM has paid $276,000 in taxes.
| Income Tax | 276,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.12% in the last 52 weeks. The beta is 2.86, so ITRM's price volatility has been higher than the market average.
| Beta (5Y) | 2.86 |
| 52-Week Price Change | -76.12% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 0.74 |
| Relative Strength Index (RSI) | 51.13 |
| Average Volume (20 Days) | 968,421 |
Short Selling Information
The latest short interest is 1.72 million, so 3.25% of the outstanding shares have been sold short.
| Short Interest | 1.72M |
| Short Previous Month | 1.76M |
| Short % of Shares Out | 3.25% |
| Short % of Float | 3.27% |
| Short Ratio (days to cover) | 1.70 |
Income Statement
In the last 12 months, ITRM had revenue of $390,000 and -$26.96 million in losses. Loss per share was -$0.74.
| Revenue | 390,000 |
| Gross Profit | 116,000 |
| Operating Income | -20.64M |
| Pretax Income | -26.69M |
| Net Income | -26.96M |
| EBITDA | -19.32M |
| EBIT | -20.64M |
| Loss Per Share | -$0.74 |
Full Income StatementBalance Sheet
The company has $11.00 million in cash and $33.74 million in debt, with a net cash position of -$22.73 million or -$0.43 per share.
| Cash & Cash Equivalents | 11.00M |
| Total Debt | 33.74M |
| Net Cash | -22.73M |
| Net Cash Per Share | -$0.43 |
| Equity (Book Value) | -7.38M |
| Book Value Per Share | -0.15 |
| Working Capital | 7.30M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$19.51 million and capital expenditures -$14,000, giving a free cash flow of -$19.53 million.
| Operating Cash Flow | -19.51M |
| Capital Expenditures | -14,000 |
| Free Cash Flow | -19.53M |
| FCF Per Share | -$0.37 |
Full Cash Flow StatementMargins
| Gross Margin | 29.74% |
| Operating Margin | -5,292.31% |
| Pretax Margin | -6,842.31% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ITRM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -124.80% |
| Shareholder Yield | -124.80% |
| Earnings Yield | -140.57% |
| FCF Yield | -101.82% |
Analyst Forecast
The average price target for ITRM is $9.00, which is 2,379.34% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.00 |
| Price Target Difference | 2,379.34% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 18, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Aug 18, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
ITRM has an Altman Z-Score of -23.03 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -23.03 |
| Piotroski F-Score | 2 |
